Friday, September 23, 2022


Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction

Cellistic, the cell therapy development and manufacturing business of Ncardia BV, and Celyad Oncology, a clinical-stage biotechnology company focused on the discovery and development...

Astellas and MBC BioLabs Announce Astellas Future Innovator Prize to Help Biotech Start-ups

Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and Mission Bay Capital BioLabs ("MBC BioLabs"), a life-science incubator, today...

Advanced NanoTherapies’ SirPlux Duo Drug-Coated Balloon Receives FDA Breakthrough Designation

Advanced NanoTherapies, Inc., a privately-held medical device company committed to solving vascular disease's most significant challenges through the creative applications of nanotechnology, today announced...

Breadth of Abbott’s Minimally Invasive Structural Heart Technologies

Abbott announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in treating people with a range of structural heart...

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke

Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL Cerebral Protection System, which is designed to capture and...

Hot Topics